Compare WEYS & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WEYS | TOI |
|---|---|---|
| Founded | 1906 | 2007 |
| Country | United States | United States |
| Employees | N/A | 641 |
| Industry | Apparel | Medical/Nursing Services |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 331.9M | 304.4M |
| IPO Year | 1995 | N/A |
| Metric | WEYS | TOI |
|---|---|---|
| Price | $34.54 | $4.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.67 |
| AVG Volume (30 Days) | 12.0K | ★ 1.6M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.24% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $276,169,000.00 | N/A |
| Revenue This Year | N/A | $30.15 |
| Revenue Next Year | N/A | $25.77 |
| P/E Ratio | $54.14 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $27.25 | $2.02 |
| 52 Week High | $35.69 | $4.88 |
| Indicator | WEYS | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 55.13 | 72.23 |
| Support Level | $30.62 | $3.02 |
| Resistance Level | N/A | $4.88 |
| Average True Range (ATR) | 1.38 | 0.26 |
| MACD | 0.10 | 0.02 |
| Stochastic Oscillator | 75.59 | 99.37 |
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, South Africa, and Australia.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.